First, we evaluated the RIPK1 and TNFα receptor expression in both normal brain tissue and GBM biopsies and we found higher expression levels of both transcripts and a greater distribution in the GBM tissues, with detectable expression in 25% and 81% of the clusters, respectively (Figure 7A). Here, RIPK1 is linked to glioblastoma.